修改/脂质相关核酸 (PLANA) 用于CRISPR/Cas9核蛋白输送
Abdulelah Alhazza1, Parvin Mahdipoor2, Ryley Hall2
1Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618, USA; Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Rafha, 76313, Saudi Arabia.
概括
化/脂质相关核酸 (PLANA) 是一种更安全,更有效的方法,可以将CRISPR/Cas9核核蛋白输送到细胞中进行基因组编辑. 这一进步解决了以前的毒性问题,为未来的体内应用铺平了道路.
科学领域:
- 分子生物学分子生物学
- 基因编辑技术的技术
- 纳米技术在医学中的应用
背景情况:
- 使用集群定期间隔的短Palindromic重复 (CRISPR) 和CRISPR相关的蛋白9 (Cas9) 的基因组编辑使人们对用于蛋白沉默的核酸输送重新产生了兴趣.
- 将CRISPR/Cas9组件输入细胞核具有重大挑战,特别是与小干扰RNA (siRNA) 的细胞质输送相比.
- 之前的工作为siRNA传递引入了/脂相关核酸 (PLANAs),需要对CRISPR/Cas9应用进行进一步的研究.
研究的目的:
- 评估/脂相关核酸 (PLANA) 的效率和安全性,用于体外输送CRISPR/Cas9核糖蛋白.
- 通过引入聚乙烯糖醇 (PEG) 修改来解决与非PEGylated PLANAs观察到的毒性问题.
主要方法:
- 通过将PEG结合脂质纳入纳米粒子组合物中来实现PLANA的PEG化.
- 在PEGylated和非PEGylatedPLANAs中评估了体外传染效率和细胞内化.
- 量化了毒性,封装效率和表面PEGylation水平.
- 下一代测序用于分析转染细胞中的基因编辑结果 (indels).
主要成果:
- PEGylation显著降低了PLANA的毒性,而不会显著损害封装效率.
- PEGylated PLANAs的细胞内化和转染效率与非PEGylated版本和商业试剂 (LipofectamineTM CRISPRMAXTM) 相同.
- 下一代测序证实了转染细胞群体中各种内基的存在,表明成功的CRISPR/Cas9活动.
结论:
- 基化PLANA是一种有效和更安全的替代品,用于在体外输送CRISPR/Cas9核糖蛋白.
- 增强的PEGylated PLANA的安全性使得它们成为未来体内基因组编辑研究的有希望的候选者.
- 这项研究强调了纳米技术在增强基因编辑工具的交付方面的潜力.
相关概念视频
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


